Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Murthy

Showing results (821-830 of 873) with videos related to

Pageof 88
Sort By:
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel DiseaseEric I Benchimol, Matthew W Carroll, Rose Geist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2019
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline <i>BRCA</i> Pathogenic VariantJennifer K Litton, Marion E Scoggins, Kenneth R Hess, et al.
Inflammatory Bowel Diseases|March 14, 2023
Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort StudyMichael J Buie, Stephanie Coward, Abdel-Aziz Shaheen, et al.
JAMA Oncology|November 29, 2016
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and BevacizumabReva K Basho, Michael Gilcrease, Rashmi K Murthy, et al.
Movement Disorders Clinical Practice|April 11, 2022
Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired DisordersConor Fearon, Sapna Rawal, Diana Olszewska, et al.
Science (New York, N.Y.)|January 8, 2005
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibilityEnrique Gonzalez, Hemant Kulkarni, Hector Bolivar, et al.
ESMO Open|January 4, 2025
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasisR Bartsch, J M Pérez-García, J Furtner, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|November 14, 2014
Short-term outcomes after perinatal hypoxic ischemic encephalopathy: a report from the Children's Hospitals Neonatal Consortium HIE focus groupA N Massaro, K Murthy, I Zaniletti, et al.
British Journal of Cancer|May 18, 2019
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatmentBora Lim, Rashmi K Murthy, Jangsoon Lee, et al.
The American Journal of Gastroenterology|April 19, 2017
Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative DatabasesEric I Benchimol, Charles N Bernstein, Alain Bitton, et al.
Pageof 88

Showing results (821-830 of 873) with videos related to

Sort By:
Pageof 88
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel DiseaseEric I Benchimol, Matthew W Carroll, Rose Geist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2019
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline <i>BRCA</i> Pathogenic VariantJennifer K Litton, Marion E Scoggins, Kenneth R Hess, et al.
Inflammatory Bowel Diseases|March 14, 2023
Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort StudyMichael J Buie, Stephanie Coward, Abdel-Aziz Shaheen, et al.
JAMA Oncology|November 29, 2016
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and BevacizumabReva K Basho, Michael Gilcrease, Rashmi K Murthy, et al.
Movement Disorders Clinical Practice|April 11, 2022
Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired DisordersConor Fearon, Sapna Rawal, Diana Olszewska, et al.
Science (New York, N.Y.)|January 8, 2005
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibilityEnrique Gonzalez, Hemant Kulkarni, Hector Bolivar, et al.
ESMO Open|January 4, 2025
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasisR Bartsch, J M Pérez-García, J Furtner, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|November 14, 2014
Short-term outcomes after perinatal hypoxic ischemic encephalopathy: a report from the Children's Hospitals Neonatal Consortium HIE focus groupA N Massaro, K Murthy, I Zaniletti, et al.
British Journal of Cancer|May 18, 2019
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatmentBora Lim, Rashmi K Murthy, Jangsoon Lee, et al.
The American Journal of Gastroenterology|April 19, 2017
Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative DatabasesEric I Benchimol, Charles N Bernstein, Alain Bitton, et al.
Pageof 88